Yoko Fujita-Yamaguchi

Title: Yoko Fujita-Yamaguchi: Innovator in Recombinant Proteins and Antibody Research

Introduction

Yoko Fujita-Yamaguchi is a prominent inventor based in Glendora, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins and antibodies. With a total of 4 patents, her work has the potential to impact various medical applications.

Latest Patents

One of her latest patents is titled "Recombinant lectin and uses thereof." This patent discloses a recombinant S27S5 hemagglutinin (SHA) and its homologues, along with a fusion protein that combines a fluorescent protein, such as GFP or mCherry1, with SHA. These proteins specifically bind to carbohydrates, including oligomeric sugars that terminate in L-rhamnose or D-galactose. The applications of SHA and its homologues extend to the detection of various microorganisms and cancer or tumor antigens. Another notable patent is "Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth." This patent outlines a method for inhibiting the growth of hormone-dependent tumor cells in mammals by administering a recombinant antibody targeting the insulin-like growth factor receptor (IGF-IR).

Career Highlights

Yoko has worked with esteemed institutions such as City of Hope and Washington University. Her research has focused on innovative solutions in the field of cancer treatment and diagnostics.

Collaborations

Throughout her career, Yoko has collaborated with notable colleagues, including Jay M McDonald and David B Sacks. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Yoko Fujita-Yamaguchi is a trailblazer in the field of biotechnology, with her patents paving the way for advancements in medical diagnostics and cancer treatment. Her innovative work continues to inspire future research and development in the industry.